RTI Surgical (RTIX) Downgraded by BidaskClub to “Sell”

RTI Surgical (NASDAQ:RTIX) was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating in a report issued on Tuesday.

Separately, Zacks Investment Research raised shares of RTI Surgical from a “sell” rating to a “hold” rating in a research note on Friday, October 13th.

Shares of RTI Surgical (NASDAQ RTIX) remained flat at $$4.50 during midday trading on Tuesday. 83,817 shares of the company traded hands, compared to its average volume of 108,912. RTI Surgical has a twelve month low of $3.01 and a twelve month high of $6.00. The firm has a market cap of $273.74, a P/E ratio of 112.50, a P/E/G ratio of 6.00 and a beta of 1.76. The company has a debt-to-equity ratio of 0.25, a current ratio of 3.34 and a quick ratio of 1.21.

RTI Surgical (NASDAQ:RTIX) last announced its earnings results on Thursday, November 2nd. The medical equipment provider reported $0.01 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.01. RTI Surgical had a net margin of 1.01% and a return on equity of 2.29%. The business had revenue of $66.69 million during the quarter, compared to the consensus estimate of $65.63 million. The company’s quarterly revenue was up .2% compared to the same quarter last year. equities research analysts anticipate that RTI Surgical will post 0.05 earnings per share for the current year.

Several large investors have recently bought and sold shares of RTIX. Cigna Investments Inc. New purchased a new stake in shares of RTI Surgical during the second quarter valued at approximately $105,000. Prudential Financial Inc. purchased a new stake in shares of RTI Surgical during the third quarter valued at approximately $111,000. Citadel Advisors LLC grew its holdings in shares of RTI Surgical by 85.7% during the third quarter. Citadel Advisors LLC now owns 26,786 shares of the medical equipment provider’s stock valued at $122,000 after buying an additional 12,361 shares during the last quarter. Citigroup Inc. grew its holdings in shares of RTI Surgical by 2,850.1% during the second quarter. Citigroup Inc. now owns 21,152 shares of the medical equipment provider’s stock valued at $124,000 after buying an additional 20,435 shares during the last quarter. Finally, Campbell & CO Investment Adviser LLC purchased a new stake in shares of RTI Surgical during the third quarter valued at approximately $144,000. Hedge funds and other institutional investors own 69.92% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2017/12/10/rti-surgical-rtix-downgraded-by-bidaskclub-to-sell.html.

About RTI Surgical

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Receive News & Ratings for RTI Surgical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply